510(k) Report

510(k) · Cleared

Cleared

BD PosiFlush Heparin Lock Flush Syringe

K163591510(k) SpecialCleared Feb 27, 201769-day reviewClass II21 CFR 880.5200

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Becton, Dickinson and Company · NZW Heparin, Vascular Access Flush

Cleared on Feb 27, 2017 as substantially equivalent to K090680 (Becton, Dickinson & CO, 2009) after a 69-day review. Its family tree reaches back 4 generations to 1995.

Decided
Feb 27, 2017
Review
69 days
Class
Class II
Product code
NZW
Recalls
None
Predicates
1

Its longest line of descent runs back 4 generations to K952645 (1995). 8 ancestors in all, the oldest K953120 (1995). No later device cites it as a predicate yet.

  1. Root · 4 generations backK952645 Vital Signs Saline Vascular Access Flush DeviceVital Signs, Inc. · 1995
  2. 3 generations backK982558 BD Preefile Normal Saline Flush Syringe Flush SyringeBd/Preefil · 2000
  3. 2 generations backK011967 BD Pre-Filled Heparin Lock Flush in 0.9% Sodium Chloride Injection…Bd · 2002
  4. 1 generation backK090680 Heparin Lock Flush Solution, Usp BD Posiflush Heparin Lock Flush…Becton, Dickinson & CO · 2009
  5. This deviceK163591 BD PosiFlush Heparin Lock Flush SyringeBecton, Dickinson and Company · 2017
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−4K952645Vital Signs Saline Vascular Access Flush DeviceVital Signs, Inc.1995—
−3K982558BD Preefile Normal Saline Flush Syringe Flush SyringeBd/Preefil2000—
−2K011967BD Pre-Filled Heparin Lock Flush in 0.9% Sodium Chloride Injection, Usp SyringeBd2002—
−1K090680Heparin Lock Flush Solution, Usp BD Posiflush Heparin Lock Flush SyringeBecton, Dickinson & CO2009—
0 (this device)K163591BD PosiFlush Heparin Lock Flush SyringeBecton, Dickinson and Company2017—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199510
200010
200120
FIG. 1 — Lineage of K163591, 1995–2017Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in NZW? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K090680Heparin Lock Flush Solution, Usp BD Posiflush Heparin Lock Flush Syringe
Summary page 4
…Solution, USP- BD PosiFlush™ Heparin Lock Flush Syringe 510(k) Reference: K090680 Common Name: Heparin, Vascular Access Flush Classificatio…
Becton, Dickinson & CO2009—

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 22 years and passes through 5 companies; a new generation was cleared every 7.4 years on median.
  • 1 of the 8 ancestors has a recall of any class.

How does its category compare?

All NZW devices

NZW Heparin, Vascular Access Flush: FDA decisions, review times, recalls and adverse event reports over 20 years. 2017, this device’s year, is highlighted.

FDA decisions per year · NZW

1in 2017

2007: 12009: 12010: 22014: 12017: 1
2007high 2 (2010) · low 0 (2008)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · NZW

Too few NZW 510(k)s in any year since 2007 to give a median.

Recalls per year · NZW

1in 2014

2008: 222010: 32012: 12014: 1
2007high 22 (2008) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · NZW

11in 2025

2007: 212008: 2912009: 1222010: 1942011: 332012: 92013: 152014: 82015: 52017: 32018: 192019: 192020: 32021: 102022: 142023: 92024: 102025: 11
2007high 291 (2008) · low 0 (2016)2025

MAUDE reports naming product code NZW, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—021
20080—22291
20091—0122
20102—3194
20110—033
20120—19
20130—015
20141—18
20150—05
20160—00
20171—03
20180—019
20190—019
20200—03
20210—010
20220—014
20230—09
20240—010
20250—011
20260—0—

What is it indicated for?

The Heparin Lock Flush Solution, USP, BD PosiFlush™ Heparin Lock Flush Syringes are intended for maintenance of patency of vascular access devices only.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K163591: BD PosiFlush Heparin Lock Flush Syringe.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K163591

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026